Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study. [electronic resource]
Producer: 20200409Description: e28032 p. digitalISSN:- 1545-5017
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bayes Theorem
- Central Nervous System Neoplasms -- drug therapy
- Cerebellar Neoplasms -- drug therapy
- Child
- Child, Preschool
- Drug Resistance, Neoplasm -- drug effects
- Female
- Follow-Up Studies
- Humans
- Infant
- Male
- Medulloblastoma -- drug therapy
- Neoplasm Recurrence, Local -- drug therapy
- Neuroectodermal Tumors, Primitive -- drug therapy
- Prognosis
- Salvage Therapy
- Survival Rate
- Temozolomide -- administration & dosage
- Topotecan -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.